Dr. Imran A. Khalidi, MD

Dr. Khalidi practices at Saint Francis Hospital in Tulsa, Oklahoma, part of Saint Francis Health System.

Dr. Khalidi's NPI, 1780661728, was assigned on December 30, 2005. Dr. Khalidi holds Oklahoma license 24412.

Dr. Khalidi's primary practice is Saint Francis Hospital, at 6161 South Yale, Tulsa, OK 74136 in Tulsa County. The practice phone is (918) 494-8467.

Dr. Khalidi's primary practice is Saint Francis Hospital in Tulsa, Oklahoma, part of Saint Francis Health System. Dr. Khalidi is also affiliated with Saint Francis Hospital South. The medical group on file is Warren Clinic.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Khalidi practices, 2 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Khalidi's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dr. Khalidi is licensed in Oklahoma.

CMS data shows 1,172 Medicare services from Dr. Khalidi across 5 procedure codes in 2024, for 278 Medicare patients. Medicare paid $99,646 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 278 Medicare patients who saw Dr. Khalidi in 2024. The largest group is 75 to 84, with 101 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 28% are also on Medicaid. Their average risk score is 3.07, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Khalidi's median patient age at 72, with 53% women.

In 2024, Dr. Khalidi wrote 751 Medicare Part D claims for 218 patients. 91% of them were for generic drugs. CMS names the drug for 465 of them, across 20 drugs with 11 or more claims each, at $4,837 in total drug cost. In 2023, CMS named 220 claims across 11 drugs.

Dr. Khalidi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 26 general payments to Dr. Khalidi from 10 drug and device companies from 2016 to 2019. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $94.